This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Modernatx, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Celebrating the Innovations of Andrea Lea Frassetto
Introduction
Andrea Lea Frassetto is a prominent inventor based in Haverhill, Massachusetts, recognized for her significant contribution to the field of biotechnology. With a focus on mRNA therapies, she has developed innovative solutions that address critical medical conditions.
Latest Patents
Andrea holds a patent for her groundbreaking work titled "Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders." This patent relates to mRNA therapy specifically designed for the treatment of ornithine transcarbamylase deficiency (OTCD). The invention involves the use of mRNAs that, when administered in vivo, encode human ornithine transcarbamylase (OTC) along with its isoforms, functional fragments, and fusion proteins. Importantly, these mRNAs are encapsulated in lipid nanoparticles (LNPs) to ensure effective delivery to the target cells or tissues. The therapies developed under this patent have the potential to increase or restore deficient levels of OTC expression and activity in subjects, thereby reducing toxic ammonia levels associated with insufficient OTC activity.
Career Highlights
Andrea is currently employed at ModernaTX, Inc., a leading biotechnology company known for its innovation in messenger RNA (mRNA) technology. Her work plays a vital role in shaping the future of mRNA therapies and significantly impacts the treatment landscape for urea cycle disorders.
Collaborations
Throughout her career, Andrea has collaborated with accomplished professionals such as Zhijian Zhuo and Paolo G. V. Martini. These collaborations have fostered a rich exchange of ideas and expertise, contributing to the advancement of research and innovation in their respective fields.
Conclusion
Andrea Lea Frassetto stands out as an influential figure in the realm of biotechnology, particularly through her work on mRNA therapies. Her patent and contributions at ModernaTX, Inc. not only showcase her ingenuity but also have the potential to make a lasting impact on the treatment of urea cycle disorders. As the medical field continues to evolve, her innovative spirit and dedication to her work highlight the importance of research and collaboration in driving forward advancements that can improve patient lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile